Smartphone-Based Program for Vaping Cessation

Overseen By Craig Fujii

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Pivot Health Technologies Inc.

Disqualifiers: Cigarette use, Recent smoker, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

73 Participants Needed

Trial Summary

What is the purpose of this trial?

Prospective, open label, single center clinical study enrolling up to 100 participants to evaluate the effect of the Pivot vaping cessation program.

Research Team

Jennifer Marler, MD

Principal Investigator

Pivot Health Technologies Inc.

Eligibility Criteria

This trial is for daily nicotine vape users in the U.S. who plan to quit within 30 days, can read English, and are willing to use a smartphone app (iPhone 5/iOS 12 or Android 7.0+) with internet access for cessation coaching. Ex-smokers must have quit over 3 months ago and participants cannot be using other vaping cessation programs.

Inclusion Criteria

Willing to sign the Informed Consent Form (ICF)

I plan to quit vaping within the next 6 months.

Resident of the United States

Exclusion Criteria

Currently using cigarettes

I am not using any other vaping cessation programs.

Failure to provide contact or collateral information, and/or failure to verify email address

Treatment Details

Interventions

• Pivot

Trial Overview The study tests the 'Pivot for Vape' program's effectiveness in helping people stop vaping. It's an open label pilot study enrolling up to 100 participants who will receive support through a smartphone-based cessation program.

Participant Groups

Group I: Pivot for Vape Experimental Treatment 1 Intervention

A commercially available mobile phone app and program for vaping cessation

Who Is Running the Clinical Trial?

Pivot Health Technologies Inc.

Lead Sponsor

Trials

4

Recruited

490+